speb/financial-data huggingface dataset:
Financial ratios for NEO.TO — annual report dated 2023-12-31
Total revenue: 432988636.3636363
Gross profit: 75078787.87878788
Operating income: 9757575.757575758
Net income: -6356818.181818182
Capital expenditures: 31623484.848484848
Operating cash flow: 46198484.848484844
Depreciation & amortization: 12737121.212121211
Net tangible assets: 248845454.54545453
Owner earnings: -25243181.81818182
Return on net tangible assets (%): -10.144120118364814
Capex to operating income (%): 324.0916149068323
Buffett classification: The Gruesome
Stock price: 5.265151515151515
Shares outstanding: 45991972
Book value: 329781060.60606056
P/B ratio: 0.7342892906450791
Market cap (USD): 242154701.06060603
Debt to equity: 0.06758386532846632
Current ratio: 3.080980357055674
Quick ratio: 1.4742867837323221
Effective tax rate (%): 189.35170178282013
Interest coverage ratio: 28.30769230769231
COGS to revenue (%): 82.66033295715998
R&D to revenue (%): 2.8246244827616374
SG&A to revenue (%): 11.00403292829086
Free cash flow (dilution-adjusted): 11743181.818181818
Buyback yield (%): 6.223482129171112
Retained earnings: -21625000
Inventory turnover: 2.392675725362491
Receivables turnover: 7.132187780772686
Capitalized R&D asset: 22482288.324420676
ROCI (R&D-adjusted, %): 3.1679362043972223
Rosenberg metric: -2.2710643193103555
FCF margin (%): 2.7121224050599695
Revenue growth (%): -8.032737029547889
Rule of 40 score: -5.320614624487919
Financial ratios for NEO.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.762962962962963
Shares outstanding: 45991972
Market cap (USD): 265050031.2296296
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEO.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.363636363636364
Shares outstanding: 45991972
Market cap (USD): 246684213.45454547
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEO.TO — annual report dated 2024-12-31
Total revenue: 332746853.14685315
Gross profit: 86685314.68531469
Operating income: 24782517.482517485
Net income: -9053146.853146853
Capital expenditures: 44896503.4965035
Operating cash flow: 35665034.96503497
Depreciation & amortization: 11010489.51048951
Net tangible assets: 212978321.6783217
Owner earnings: -42939160.839160845
Return on net tangible assets (%): -20.161282378783753
Capex to operating income (%): 181.16199667033496
Buffett classification: The Gruesome
Stock price: 5.363636363636364
Shares outstanding: 45991972
Book value: 283134265.73426574
P/B ratio: 0.8712623066473689
Market cap (USD): 246684213.45454547
Debt to equity: 0.18773124021319793
Current ratio: 2.229141183186235
Quick ratio: 1.3552005118651083
Effective tax rate (%): 258.2014388489208
Interest coverage ratio: 19.197724810400867
COGS to revenue (%): 73.9485696512185
R&D to revenue (%): 3.545188597560463
SG&A to revenue (%): 13.546911909345393
Free cash flow (dilution-adjusted): -11371328.671328671
Buyback yield (%): 0.6378302654200838
Retained earnings: -37683216.78321678
Inventory turnover: 2.525591978237308
Receivables turnover: 6.260482862969541
Capitalized R&D asset: 25040291.820924174
ROCI (R&D-adjusted, %): 6.336611407979579
Rosenberg metric: 0.9489974841808344
FCF margin (%): -3.417411333507066
Revenue growth (%): -23.151134879345246
Rule of 40 score: -26.56854621285231
Financial ratios for NEO.TO — quarterly report dated 2025-03-31
Total revenue: 85041958.04195805
Gross profit: 21544055.944055945
Operating income: 6705594.405594406
Net income: -969930.06993007
Capital expenditures: 7991608.391608392
Operating cash flow: -12360839.16083916
Depreciation & amortization: 2588811.188811189
Net tangible assets: 214472727.27272728
Owner earnings: -6372727.272727273
Return on net tangible assets (%): -2.971346219057308
Capex to operating income (%): 119.17822504953592
Buffett classification: The Gruesome
Stock price: 5.8671328671328675
Shares outstanding: 45991972
Book value: 282695804.19580424
P/B ratio: 0.9545278229830181
Market cap (USD): 269841010.54545456
Debt to equity: 0.1864466735105317
Current ratio: 2.413778272723782
Quick ratio: 1.3107637955531664
Effective tax rate (%): 168.2502896871379
Interest coverage ratio: 16.11596638655462
COGS to revenue (%): 74.66655702656033
R&D to revenue (%): 2.6264287476358854
SG&A to revenue (%): 13.357454156730533
Free cash flow (dilution-adjusted): -21006993.006993007
Buyback yield (%): 0
Retained earnings: -40779720.279720284
Inventory turnover: 0.6322466543190965
Receivables turnover: 1.457681565919906
Capitalized R&D asset: 2233566.433566434
ROCI (R&D-adjusted, %): 2.3715657663419125
FCF margin (%): -24.701915960858482
Rule of 40 score: -24.701915960858482
Financial ratios for NEO.TO — quarterly report dated 2025-06-30
Total revenue: 83722627.73722628
Gross profit: 24752554.744525544
Operating income: 5992700.729927007
Net income: 4213138.686131386
Capital expenditures: 6488321.167883211
Operating cash flow: -3775182.4817518247
Depreciation & amortization: 2732846.715328467
Net tangible assets: 224714598.54014596
Owner earnings: 457664.23357664235
Return on net tangible assets (%): 0.20366466466791616
Capex to operating income (%): 108.27040194884286
Buffett classification: The Gruesome
Stock price: 10.416058394160583
P/E ratio: 147.71022240798771
Shares outstanding: 45991972
Book value: 295694890.5109489
P/B ratio: 1.6200992353530714
Market cap (USD): 479055066.0145985
Debt to equity: 0.24121085553761767
Current ratio: 2.4581766469480058
Quick ratio: 1.3828718873470704
Effective tax rate (%): 22.156020507135928
Interest coverage ratio: 6.531424025457439
COGS to revenue (%): 70.43504795117698
R&D to revenue (%): 3.606800348735832
SG&A to revenue (%): 17.296425457715777
Free cash flow (dilution-adjusted): -12827737.22627737
Buyback yield (%): 0.35684604388314645
Retained earnings: -40740875.912408754
Inventory turnover: 0.5507389632699806
Receivables turnover: 1.1494483249321055
Capitalized R&D asset: 4516197.53968659
ROCI (R&D-adjusted, %): 1.9048715209022806
Rosenberg metric: 1.4364913226898957
FCF margin (%): -15.321708805579771
Revenue growth (%): -1.5513874975466104
Rule of 40 score: -16.87309630312638
Financial ratios for NEO.TO — quarterly report dated 2025-09-30
Total revenue: 87923021.58273382
Gross profit: 24031654.676258996
Operating income: 6017266.18705036
Net income: 980575.5395683454
Capital expenditures: 5632374.100719425
Operating cash flow: -1825179.8561151081
Depreciation & amortization: 2730215.8273381297
Net tangible assets: 221306474.8201439
Owner earnings: -1921582.7338129496
Return on net tangible assets (%): -0.8682903360033287
Capex to operating income (%): 93.60353897656624
Buffett classification: The Gruesome
Stock price: 14.086330935251798
P/E ratio: 153.38334395517455
Shares outstanding: 45991972
Book value: 290759712.23021585
P/B ratio: 2.22815648353606
Market cap (USD): 647858137.9568346
Debt to equity: 0.2319772563069706
Current ratio: 2.2358722681136123
Quick ratio: 1.1814346545242205
Effective tax rate (%): 81.86537773003938
Interest coverage ratio: 8.289395441030724
COGS to revenue (%): 72.66739217595509
R&D to revenue (%): 3.42107631757669
SG&A to revenue (%): 15.600631684027066
Free cash flow (dilution-adjusted): -10393525.179856116
Buyback yield (%): 0.17178909626692432
Retained earnings: -41342446.04316547
Inventory turnover: 0.5526040694418518
Receivables turnover: 1.1360725075528701
Capitalized R&D asset: 5768194.971703716
ROCI (R&D-adjusted, %): 1.6825911536477802
Rosenberg metric: -0.2387317122371697
FCF margin (%): -11.821164687880994
Revenue growth (%): 5.017035369089224
Rule of 40 score: -6.80412931879177
Financial ratios for NEO.TO — annual report dated 2025-12-31
Total revenue: 349483941.6058394
Gross profit: 97681751.82481751
Operating income: 23178102.18978102
Net income: -7276642.335766423
Capital expenditures: 23112408.759124085
Operating cash flow: -39388321.16788321
Depreciation & amortization: 10953284.671532845
Net tangible assets: 214080291.9708029
Owner earnings: -19435766.42335766
Return on net tangible assets (%): -9.078727539295578
Capex to operating income (%): 99.7165711406437
Buffett classification: The Gruesome
Stock price: 11.27737226277372
Shares outstanding: 45991972
Book value: 285013138.68613136
P/B ratio: 1.8198058929284857
Market cap (USD): 518668589.3430656
Debt to equity: 0.2702859133142793
Current ratio: 1.8331516417850184
Quick ratio: 0.7964751839626926
Effective tax rate (%): 397.9552362531086
Interest coverage ratio: 9.241559953434226
COGS to revenue (%): 72.04971668341017
R&D to revenue (%): 3.9029392660293696
SG&A to revenue (%): 15.944259836714405
Free cash flow (dilution-adjusted): -71229197.08029197
Buyback yield (%): 0.5622199713026771
Retained earnings: -55536496.35036496
Inventory turnover: 1.6794576568243227
Receivables turnover: 4.517938023703479
Capitalized R&D asset: 25579803.3280588
ROCI (R&D-adjusted, %): 6.370291915598145
Rosenberg metric: 0.9321776696596737
FCF margin (%): -20.381250352448767
Revenue growth (%): 5.0299764823319135
Rule of 40 score: -15.351273870116852
Financial ratios for NEO.TO — quarterly report dated 2025-12-31
Total revenue: 87788321.1678832
Gross profit: 26059124.08759124
Operating income: 4081021.897810219
Net income: -11407299.270072991
Capital expenditures: 2567883.211678832
Operating cash flow: -20859124.08759124
Depreciation & amortization: 2748175.182481752
Net tangible assets: 214080291.9708029
Owner earnings: -11227007.299270071
Return on net tangible assets (%): -5.244297453032834
Capex to operating income (%): 62.922554104811304
Buffett classification: The Good
Stock price: 11.27737226277372
Shares outstanding: 45991972
Book value: 285013138.68613136
P/B ratio: 1.8198058929284857
Market cap (USD): 518668589.3430656
Debt to equity: 0.2702859133142793
Current ratio: 1.8331516417850184
Quick ratio: 0.7964751839626926
Interest coverage ratio: 7.122292993630574
COGS to revenue (%): 70.31595576619273
R&D to revenue (%): 5.965743743244367
SG&A to revenue (%): 17.61952274050054
Free cash flow (dilution-adjusted): -25929197.080291968
Buyback yield (%): 0.014917476084626728
Retained earnings: -55536496.35036496
Inventory turnover: 0.41171831260193276
Receivables turnover: 1.1348795953800859
Capitalized R&D asset: 8249032.08528068
ROCI (R&D-adjusted, %): 1.5303115675893728
Rosenberg metric: 0.6740450805433668
FCF margin (%): -29.536043901222246
Revenue growth (%): -0.15320266799961144
Rule of 40 score: -29.689246569221858
Financial ratios for NRA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.51136363636364
Shares outstanding: 210986470
Market cap (USD): 8336363138.522728
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NRA.DE — annual report dated 2022-12-31
Total revenue: 31543000000
Gross profit: 4100000000
Operating income: 2224000000
Net income: 1221000000
Capital expenditures: 373000000
Operating cash flow: 360000000
Depreciation & amortization: 720000000
Net tangible assets: 46000000
Owner earnings: 1568000000
Return on net tangible assets (%): 3408.6956521739135
Capex to operating income (%): 16.771582733812952
Buffett classification: The Great
Stock price: 30.5531914893617
P/E ratio: 5.2795331855646745
Shares outstanding: 210986470
Book value: 3828000000
P/B ratio: 1.6839890333266634
Market cap (USD): 6446310019.574468
Debt to equity: 2.168756530825496
Current ratio: 1.25026960406717
Quick ratio: 1.1924202742258512
Effective tax rate (%): 26.578472639807575
Interest coverage ratio: 5.333333333333333
COGS to revenue (%): 87.1033192784453
SG&A to revenue (%): 3.629965443997083
Free cash flow (dilution-adjusted): -41000000
Buyback yield (%): 9.400726898952389
Retained earnings: 1408000000
Inventory turnover: 36.58455392809587
Receivables turnover: 6.608631887701655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.758970551843602
FCF margin (%): -0.12998129537456804
Rule of 40 score: -0.12998129537456804
Financial ratios for NRA.DE — annual report dated 2023-12-31
Total revenue: 28823000000
Gross profit: 2340000000
Operating income: -1049000000
Net income: -202000000
Capital expenditures: 622000000
Operating cash flow: -221000000
Depreciation & amortization: 1295000000
Net tangible assets: -6100000000
Owner earnings: 471000000
Buffett classification: The Gruesome
Stock price: 41.91111111111111
Shares outstanding: 210986470
Book value: 2906000000
P/B ratio: 3.04290343672096
Market cap (USD): 8842677387.11111
Debt to equity: 3.775292498279422
Current ratio: 1.0238947368421052
Quick ratio: 0.96
Interest coverage ratio: -1.5727136431784108
COGS to revenue (%): 92.30128716649898
SG&A to revenue (%): 7.265031398535891
Free cash flow (dilution-adjusted): -944000000
Buyback yield (%): 13.253904317580115
Retained earnings: 820000000
Inventory turnover: 43.828665568369026
Receivables turnover: 8.137492941840767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.342967710726811
FCF margin (%): -3.275162196856677
Revenue growth (%): -8.623149351678661
Rule of 40 score: -11.898311548535338
Financial ratios for NRA.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 261000000
Buffett classification: The Gruesome
Stock price: 41.91111111111111
Shares outstanding: 210986470
Market cap (USD): 8842677387.11111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NRA.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 257000000
Buffett classification: The Gruesome
Stock price: 39.291666666666664
Shares outstanding: 210986470
Market cap (USD): 8290010050.416666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NRA.DE — annual report dated 2024-12-31
Total revenue: 28130000000
Gross profit: 6030000000
Operating income: 2282000000
Net income: 1125000000
Capital expenditures: 490000000
Operating cash flow: 2306000000
Depreciation & amortization: 1403000000
Net tangible assets: -5441000000
Owner earnings: 2038000000
Return on net tangible assets (%): -37.456349935673586
Capex to operating income (%): 21.472392638036812
Buffett classification: The Great
Stock price: 39.291666666666664
P/E ratio: 7.368897822592592
Shares outstanding: 210986470
Book value: 2478000000
P/B ratio: 3.3454439267218183
Market cap (USD): 8290010050.416666
Debt to equity: 4.43543179983858
Current ratio: 1.017133779643708
Quick ratio: 0.962895722228526
Effective tax rate (%): 22.306629834254142
Interest coverage ratio: 3.5053763440860215
COGS to revenue (%): 79.74404550302168
SG&A to revenue (%): 8.336295769640953
Free cash flow (dilution-adjusted): 1714000000
Buyback yield (%): 11.881770878558738
Retained earnings: 1535000000
Inventory turnover: 46.92887029288703
Receivables turnover: 8.064793577981652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.004273785258729
FCF margin (%): 6.093138997511553
Revenue growth (%): -2.4043298754466917
Rule of 40 score: 3.6888091220648613
Financial ratios for NRA.DE — quarterly report dated 2025-03-31
Total revenue: 8585000000
Gross profit: 2024000000
Operating income: 1149000000
Net income: 750000000
Capital expenditures: 220000000
Operating cash flow: 855000000
Depreciation & amortization: 326000000
Net tangible assets: -5085000000
Owner earnings: 856000000
Return on net tangible assets (%): -16.833824975417897
Capex to operating income (%): 19.147084421235856
Buffett classification: The Great
Stock price: 41
P/E ratio: 2.883481756666667
Shares outstanding: 210986470
Book value: 2777000000
P/B ratio: 3.1150325063017643
Market cap (USD): 8650445270
Debt to equity: 3.9560676989557075
Current ratio: 1.0618279569892473
Quick ratio: 1.021720430107527
Effective tax rate (%): 23.85786802030457
Interest coverage ratio: 7.049079754601227
COGS to revenue (%): 77.68200349446708
SG&A to revenue (%): 6.3948747815958065
Free cash flow (dilution-adjusted): 606000000
Buyback yield (%): 4.092274893960458
Retained earnings: 2162000000
Inventory turnover: 17.87935656836461
Receivables turnover: 2.444476082004556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.322669045949907
FCF margin (%): 7.0588235294117645
Rule of 40 score: 7.0588235294117645
Financial ratios for NRA.DE — quarterly report dated 2025-06-30
Total revenue: 6740000000
Gross profit: 1111000000
Operating income: 43000000
Net income: -104000000
Capital expenditures: 382000000
Operating cash flow: 451000000
Depreciation & amortization: 344000000
Net tangible assets: -5238000000
Owner earnings: -142000000
Capex to operating income (%): 888.3720930232558
Buffett classification: The Gruesome
Stock price: 44.37647058823529
P/E ratio: 14.493552446548899
Shares outstanding: 210986470
Book value: 2288000000
P/B ratio: 4.092148112093788
Market cap (USD): 9362834880.470589
Debt to equity: 4.858391608391608
Current ratio: 0.9332650039858786
Quick ratio: 0.8819041111490719
Interest coverage ratio: 0.2905405405405405
COGS to revenue (%): 85.26706231454006
SG&A to revenue (%): 10.741839762611276
Free cash flow (dilution-adjusted): 36000000
Buyback yield (%): 3.48185142813941
Retained earnings: 1970000000
Inventory turnover: 12.742793791574279
Receivables turnover: 1.9701841566793334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.280917227412295
FCF margin (%): 0.5341246290801187
Revenue growth (%): -21.49097262667443
Rule of 40 score: -20.956847997594313
Financial ratios for NRA.DE — quarterly report dated 2025-09-30
Total revenue: 7635000000
Gross profit: 1394000000
Operating income: 422000000
Net income: 152000000
Capital expenditures: 253000000
Operating cash flow: 484000000
Depreciation & amortization: 360000000
Net tangible assets: -5476000000
Owner earnings: 259000000
Return on net tangible assets (%): -4.72972972972973
Capex to operating income (%): 59.95260663507109
Buffett classification: The Good
Stock price: 44.37647058823529
P/E ratio: 11.732875790063392
Shares outstanding: 210986470
Book value: 1970000000
P/B ratio: 4.752708061152583
Market cap (USD): 9362834880.470589
Debt to equity: 6.147715736040609
Current ratio: 1.0532866588875924
Quick ratio: 0.9946842992350577
Effective tax rate (%): 36.134453781512605
Interest coverage ratio: 2.2566844919786098
COGS to revenue (%): 83.53634577603142
SG&A to revenue (%): 8.015717092337917
Free cash flow (dilution-adjusted): 210000000
Buyback yield (%): 3.887711410560568
Retained earnings: 2002000000
Inventory turnover: 14.110619469026549
Receivables turnover: 2.291416566626651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5956452208143683
FCF margin (%): 2.75049115913556
Revenue growth (%): 13.27893175074184
Rule of 40 score: 16.0294229098774
Financial ratios for NRA.DE — annual report dated 2025-12-31
Total revenue: 30713000000
Gross profit: 5952000000
Operating income: 1944000000
Net income: 864000000
Capital expenditures: 1148000000
Operating cash flow: 1913000000
Depreciation & amortization: 1406000000
Net tangible assets: -5645000000
Owner earnings: 1122000000
Return on net tangible assets (%): -19.87599645704163
Capex to operating income (%): 59.053497942386834
Buffett classification: The Good
Stock price: 161.69411764705882
P/E ratio: 39.485267479302834
Shares outstanding: 210986470
Book value: 1681000000
P/B ratio: 20.294628853133638
Market cap (USD): 34115271102.117645
Debt to equity: 9.888161808447352
Current ratio: 1.637439282600573
Quick ratio: 1.5800224187320961
Effective tax rate (%): 23.809523809523807
Interest coverage ratio: 2.623481781376518
COGS to revenue (%): 82.28111874450559
SG&A to revenue (%): 8.471982548106665
Free cash flow (dilution-adjusted): 631000000
Buyback yield (%): 4.112527776198475
Retained earnings: 1982000000
Inventory turnover: 54.8177874186551
Receivables turnover: 7.555473554735547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.208469518260623
FCF margin (%): 2.0545046071696027
Revenue growth (%): 9.182367579097049
Rule of 40 score: 11.236872186266652
Financial ratios for NRA.DE — quarterly report dated 2025-12-31
Total revenue: 7753000000
Gross profit: 1423000000
Operating income: 330000000
Net income: 66000000
Capital expenditures: 293000000
Operating cash flow: 123000000
Depreciation & amortization: 376000000
Net tangible assets: -5645000000
Owner earnings: 149000000
Return on net tangible assets (%): -2.6395039858281666
Capex to operating income (%): 88.7878787878788
Buffett classification: The Gruesome
Stock price: 161.69411764705882
P/E ratio: 39.485267479302834
Shares outstanding: 210986470
Book value: 1681000000
P/B ratio: 20.294628853133638
Market cap (USD): 34115271102.117645
Debt to equity: 9.888161808447352
Current ratio: 1.637439282600573
Quick ratio: 1.5800224187320961
Effective tax rate (%): -3.125
Interest coverage ratio: 1.3580246913580247
COGS to revenue (%): 83.54185476589707
SG&A to revenue (%): 9.248033019476331
Free cash flow (dilution-adjusted): -221000000
Buyback yield (%): 1.0523146626195672
Retained earnings: 1982000000
Inventory turnover: 14.049891540130151
Receivables turnover: 1.9072570725707256
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5631661219269577
FCF margin (%): -2.8505094802012123
Revenue growth (%): 1.5455140798952194
Rule of 40 score: -1.304995400305993
Financial ratios for OUT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.68
Shares outstanding: 176063510
Market cap (USD): 3464929876.7999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUT — annual report dated 2022-12-31
Total revenue: 1772100000
Gross profit: 855500000
Operating income: 282700000
Net income: 143900000
Capital expenditures: 96600000
Operating cash flow: 254100000
Depreciation & amortization: 150700000
Net tangible assets: -1589700000
Owner earnings: 198000000
Return on net tangible assets (%): -12.455180222683525
Capex to operating income (%): 34.17049876193845
Buffett classification: The Good
Stock price: 12.91
P/E ratio: 15.795551870048646
Shares outstanding: 176063510
Book value: 1349200000
P/B ratio: 1.6846871583901573
Market cap (USD): 2272979914.1
Debt to equity: 3.122665283130744
Current ratio: 0.7077592458303118
Quick ratio: 0.7077592458303118
Effective tax rate (%): 6.245847176079734
Interest coverage ratio: 2.144916540212443
COGS to revenue (%): 51.72394334405508
SG&A to revenue (%): 23.819197562214324
Free cash flow (dilution-adjusted): 123700000
Buyback yield (%): 0
Retained earnings: -1183400000
Receivables turnover: 5.616798732171157
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.198220064724919
FCF margin (%): 6.980418712262288
Rule of 40 score: 6.980418712262288
Financial ratios for OUT — annual report dated 2023-12-31
Total revenue: 1820600000
Gross profit: 857500000
Operating income: 267300000
Net income: -424500000
Capital expenditures: 86800000
Operating cash flow: 254200000
Depreciation & amortization: 160500000
Net tangible assets: -2004700000
Owner earnings: -350800000
Capex to operating income (%): 32.472876917321365
Buffett classification: The Good
Stock price: 11.87
Shares outstanding: 176063510
Book value: 730100000
P/B ratio: 2.8624487929050813
Market cap (USD): 2089873863.6999998
Debt to equity: 5.944117244213121
Current ratio: 0.6704890387858348
Quick ratio: 0.6704890387858348
Interest coverage ratio: 1.6875
COGS to revenue (%): 52.90014281006261
SG&A to revenue (%): 23.602109194770954
Free cash flow (dilution-adjusted): 139000000
Buyback yield (%): 0
Retained earnings: -1821100000
Receivables turnover: 6.330319888734353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.356820777971502
FCF margin (%): 7.63484565527848
Revenue growth (%): 2.7368658653574855
Rule of 40 score: 10.371711520635966
Financial ratios for OUT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.61
Shares outstanding: 176063510
Market cap (USD): 2924414901.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUT — annual report dated 2024-12-31
Total revenue: 1830900000
Gross profit: 881900000
Operating income: 282500000
Net income: 258700000
Capital expenditures: 90100000
Operating cash flow: 299200000
Depreciation & amortization: 151500000
Net tangible assets: -1889600000
Owner earnings: 320100000
Return on net tangible assets (%): -16.940093141405587
Capex to operating income (%): 31.893805309734514
Buffett classification: The Good
Stock price: 16.7
P/E ratio: 11.365522292230382
Shares outstanding: 176063510
Book value: 784000000
P/B ratio: 3.750332419642857
Market cap (USD): 2940260617
Debt to equity: 5.1186224489795915
Current ratio: 0.7407834101382489
Quick ratio: 0.7407834101382489
Effective tax rate (%): 4.087699739873653
Interest coverage ratio: 1.8085787451984634
COGS to revenue (%): 51.83243213720028
SG&A to revenue (%): 24.463378666229723
Free cash flow (dilution-adjusted): 178300000
Buyback yield (%): 0
Retained earnings: -1846200000
Receivables turnover: 5.997052079921389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.017808452624403
FCF margin (%): 9.738380031678409
Revenue growth (%): 0.5657475557508513
Rule of 40 score: 10.30412758742926
Financial ratios for OUT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.7
Shares outstanding: 176063510
Market cap (USD): 2940260617
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OUT — quarterly report dated 2025-03-31
Total revenue: 390700000
Gross profit: 169400000
Operating income: 14000000
Net income: -20600000
Capital expenditures: 21200000
Operating cash flow: 33600000
Depreciation & amortization: 40700000
Net tangible assets: -1962600000
Owner earnings: -1100000
Capex to operating income (%): 151.42857142857142
Buffett classification: The Gruesome
Stock price: 15.08
Shares outstanding: 176063510
Book value: 705700000
P/B ratio: 3.7622753731047185
Market cap (USD): 2655037730.8
Debt to equity: 5.735298285390392
Current ratio: 0.6064552661381654
Quick ratio: 0.6064552661381654
Interest coverage ratio: 0.3888888888888889
COGS to revenue (%): 56.64192475044791
SG&A to revenue (%): 29.357563347837218
Free cash flow (dilution-adjusted): 2900000
Buyback yield (%): 0
Retained earnings: -1919100000
Receivables turnover: 1.511411992263056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3041825095057034
FCF margin (%): 0.74225748656258
Rule of 40 score: 0.74225748656258
Financial ratios for OUT — quarterly report dated 2025-06-30
Total revenue: 460200000
Gross profit: 228700000
Operating income: 77100000
Net income: 19500000
Capital expenditures: 34200000
Operating cash flow: 67100000
Depreciation & amortization: 41000000
Net tangible assets: -1982700000
Owner earnings: 26300000
Return on net tangible assets (%): -1.3264740001008726
Capex to operating income (%): 44.3579766536965
Buffett classification: The Good
Stock price: 15.54
P/E ratio: 35.07726853076923
Shares outstanding: 176063510
Book value: 679800000
P/B ratio: 4.024752788172992
Market cap (USD): 2736026945.3999996
Debt to equity: 5.978817299205649
Current ratio: 0.6117140396210163
Quick ratio: 0.6117140396210163
Effective tax rate (%): 1.015228426395939
Interest coverage ratio: 2.1123287671232878
COGS to revenue (%): 50.304215558452846
SG&A to revenue (%): 24.03302911777488
Free cash flow (dilution-adjusted): 24700000
Buyback yield (%): 0
Retained earnings: -1952300000
Receivables turnover: 1.5360480640854473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6876436467111744
FCF margin (%): 5.367231638418079
Revenue growth (%): 17.788584591758383
Rule of 40 score: 23.155816230176463
Financial ratios for OUT — quarterly report dated 2025-09-30
Total revenue: 467500000
Gross profit: 236800000
Operating income: 91600000
Net income: 51400000
Capital expenditures: 24100000
Operating cash flow: 88800000
Depreciation & amortization: 40000000
Net tangible assets: -1966200000
Owner earnings: 67300000
Return on net tangible assets (%): -3.4228460990743566
Capex to operating income (%): 26.31004366812227
Buffett classification: The Good
Stock price: 17.73
P/E ratio: 62.059762073558645
Shares outstanding: 176063510
Book value: 683500000
P/B ratio: 4.5670900253108995
Market cap (USD): 3121606032.3
Debt to equity: 6.031163130943672
Current ratio: 0.7928333659682788
Quick ratio: 0.7928333659682788
Effective tax rate (%): 2.294455066921606
COGS to revenue (%): 49.3475935828877
SG&A to revenue (%): 22.502673796791445
Free cash flow (dilution-adjusted): 59100000
Buyback yield (%): 0
Retained earnings: -1953400000
Receivables turnover: 1.5262814234410709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9490191071960508
FCF margin (%): 12.641711229946523
Revenue growth (%): 1.5862668405041285
Rule of 40 score: 14.227978070450652
Financial ratios for OUT — annual report dated 2025-12-31
Total revenue: 1831700000
Gross profit: 913200000
Operating income: 311300000
Net income: 147000000
Capital expenditures: 108400000
Operating cash flow: 307600000
Depreciation & amortization: 160200000
Net tangible assets: -1908000000
Owner earnings: 198800000
Return on net tangible assets (%): -10.419287211740041
Capex to operating income (%): 34.821715387086414
Buffett classification: The Good
Stock price: 23.62
P/E ratio: 28.289932695238093
Shares outstanding: 176063510
Book value: 733900000
P/B ratio: 5.666466965799155
Market cap (USD): 4158620106.2000003
Debt to equity: 5.628832265976291
Current ratio: 0.9237117183201907
Quick ratio: 0.9237117183201907
Effective tax rate (%): 1.3651877133105803
Interest coverage ratio: 2.126366120218579
COGS to revenue (%): 50.14467434623574
SG&A to revenue (%): 24.114210842386854
Free cash flow (dilution-adjusted): 169200000
Buyback yield (%): 0
Retained earnings: -1910800000
Receivables turnover: 5.008750341810227
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.531271636279714
FCF margin (%): 9.237320521919528
Revenue growth (%): 0.043694357966027636
Rule of 40 score: 9.281014879885555
Financial ratios for OUT — quarterly report dated 2025-12-31
Total revenue: 520500000
Gross profit: 278300000
Operating income: 128600000
Net income: 96800000
Capital expenditures: 28900000
Operating cash flow: 118100000
Depreciation & amortization: 38500000
Net tangible assets: -1908000000
Owner earnings: 106400000
Return on net tangible assets (%): -5.576519916142558
Capex to operating income (%): 22.472783825816485
Buffett classification: The Great
Stock price: 23.62
P/E ratio: 28.270700925900748
Shares outstanding: 176063510
Book value: 733900000
P/B ratio: 5.666466965799155
Market cap (USD): 4158620106.2000003
Debt to equity: 5.628832265976291
Current ratio: 0.9237117183201907
Quick ratio: 0.9237117183201907
Effective tax rate (%): 0.10351966873706005
COGS to revenue (%): 45.14889529298751
SG&A to revenue (%): 21.364073006724304
Free cash flow (dilution-adjusted): 82500000
Buyback yield (%): 0
Retained earnings: -1910800000
Receivables turnover: 1.4232977850697293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6981096447978516
FCF margin (%): 15.85014409221902
Revenue growth (%): 11.336898395721926
Rule of 40 score: 27.187042487940946
Financial ratios for OVT.AX — annual report dated 2021-06-30
Total revenue: 5403546.616541353
Gross profit: 893692.4812030075
Operating income: -3623233.0827067667
Net income: -3604201.503759398
Capital expenditures: 69063.90977443609
Depreciation & amortization: 436148.8721804511
Net tangible assets: 41660830.827067666
Owner earnings: -3237116.541353383
Return on net tangible assets (%): -7.770167990145266
Buffett classification: The Gruesome
Stock price: 3.5338345864661656
Shares outstanding: 997397274
Book value: 42884288.72180451
P/B ratio: 82.18947051152023
Market cap (USD): 3524636983.308271
Debt to equity: 0.018351937222079544
Current ratio: 30.114325869124837
Quick ratio: 29.95908868865974
Interest coverage ratio: -404.74550646732735
COGS to revenue (%): 83.46100173417153
SG&A to revenue (%): 31.06695310250842
Free cash flow (dilution-adjusted): -3307017.2932330826
Buyback yield (%): 0.1062694626338286
Retained earnings: -18056004.511278193
Inventory turnover: 20.538223430555462
Receivables turnover: 1.5059348154114727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.322138336911431
FCF margin (%): -61.20086542993136
Rule of 40 score: -61.20086542993136
Financial ratios for OVT.AX — annual report dated 2022-06-30
Total revenue: 5792971.724137931
Gross profit: 1642162.0689655172
Operating income: -9048453.793103449
Net income: -6910478.620689656
Capital expenditures: 382252.4137931035
Depreciation & amortization: 353114.4827586207
Net tangible assets: 32172690.34482759
Owner earnings: -6939616.551724139
Return on net tangible assets (%): -21.569898188013433
Buffett classification: The Gruesome
Stock price: 0.5793103448275863
Shares outstanding: 997397274
Book value: 33276795.172413792
P/B ratio: 17.363527819831294
Market cap (USD): 577802558.7310345
Debt to equity: 0.021160360000682263
Current ratio: 10.275376193496008
Quick ratio: 10.275376193496008
Interest coverage ratio: -271.0741100390488
COGS to revenue (%): 71.6525101939818
SG&A to revenue (%): 97.54761090400984
Free cash flow (dilution-adjusted): -15014793.103448275
Buyback yield (%): 0
Retained earnings: -23198695.172413792
Receivables turnover: 0.3836210808048133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.757150554916485
FCF margin (%): -259.18982205428716
Revenue growth (%): 7.206842750360824
Rule of 40 score: -251.98297930392633
Financial ratios for OVT.AX — annual report dated 2023-06-30
Total revenue: 6281788.079470199
Gross profit: 1677852.9801324503
Operating income: -18561092.052980132
Net income: -24069849.006622516
Capital expenditures: 164531.7880794702
Depreciation & amortization: 429216.55629139073
Net tangible assets: 7835673.509933774
Owner earnings: -23805164.238410596
Return on net tangible assets (%): -303.8049531827902
Buffett classification: The Gruesome
Stock price: 0.543046357615894
Shares outstanding: 997397274
Book value: 7835673.509933775
P/B ratio: 69.1239822658588
Market cap (USD): 541632956.7417219
Debt to equity: 0.22259563938641297
Current ratio: 0.6910123385314222
Quick ratio: 0.6910123385314222
Interest coverage ratio: -579.338728347596
COGS to revenue (%): 73.29020083285013
SG&A to revenue (%): 60.93882241315692
Free cash flow (dilution-adjusted): -4364744.370860927
Buyback yield (%): 0
Retained earnings: -46570600.66225166
Receivables turnover: 6.2909286738479615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -235.07418815748915
FCF margin (%): -69.48251541826998
Revenue growth (%): 8.438093237974671
Rule of 40 score: -61.044422180295314
Financial ratios for OVT.AX — annual report dated 2024-06-30
Total revenue: 4028750.6666666665
Gross profit: 86131.33333333333
Operating income: -4894592.666666667
Net income: -3965356
Capital expenditures: 13976
Depreciation & amortization: 14092
Net tangible assets: 7548119.333333333
Owner earnings: -3965240
Return on net tangible assets (%): -52.53282075826571
Buffett classification: The Gruesome
Stock price: 0.19999999999999998
Shares outstanding: 997397274
Book value: 7548119.333333332
P/B ratio: 26.427702847658566
Market cap (USD): 199479454.79999998
Debt to equity: 0.1099762687023408
Current ratio: 0.41274407248585154
Quick ratio: 0.41274407248585154
Interest coverage ratio: -72.8622226191894
COGS to revenue (%): 97.86208329927261
SG&A to revenue (%): 43.95246764671132
Free cash flow (dilution-adjusted): -4285294
Buyback yield (%): 0.0882296375716784
Retained earnings: -50846427.333333336
Receivables turnover: 4.664064682737532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.84519455133152
FCF margin (%): -106.367813611697
Revenue growth (%): -35.8661798886019
Rule of 40 score: -142.2339935002989
Financial ratios for RELCHEMQ.NS — annual report dated 2023-03-31
Total revenue: 43611656.516443364
Gross profit: 19244494.518879417
Operating income: 3475395.858708892
Net income: 1512691.839220463
Capital expenditures: 6580718.635809989
Operating cash flow: -4713.763702801462
Depreciation & amortization: 1188416.5651644338
Net tangible assets: 16025980.511571256
Owner earnings: -3879610.2314250916
Return on net tangible assets (%): -24.208255018305387
Capex to operating income (%): 189.35162793957875
Buffett classification: The Gruesome
Stock price: 1.8779537149817298
P/E ratio: 9.365068147223653
Shares outstanding: 7543563
Book value: 16078818.514007308
P/B ratio: 0.8810636271382374
Market cap (USD): 14166462.160048723
Debt to equity: 1.5101142287043652
Current ratio: 0.8832968750661113
Quick ratio: 0.6096658432074892
Effective tax rate (%): 25.666916055663624
Interest coverage ratio: 3.3481184215158235
COGS to revenue (%): 55.87304850109634
SG&A to revenue (%): 9.940212544724686
Free cash flow (dilution-adjusted): -6651948.842874544
Buyback yield (%): 0
Retained earnings: 11252119.366626067
Inventory turnover: 4.4191775496138685
Receivables turnover: 48.34877660149076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.324157343894225
FCF margin (%): -15.252685575853992
Revenue growth (%): -4.81265847133374
Rule of 40 score: -20.065344047187732
Financial ratios for RELCHEMQ.NS — annual report dated 2024-03-31
Total revenue: 42685633.76903705
Gross profit: 18754335.05216453
Operating income: 2279829.7157932604
Net income: 384926.25014989806
Capital expenditures: 11102985.969540711
Operating cash flow: 2152596.234560499
Depreciation & amortization: 1214306.27173522
Net tangible assets: 15952080.585202063
Owner earnings: -9503753.447655594
Return on net tangible assets (%): -59.57688965332676
Capex to operating income (%): 487.0094416537359
Buffett classification: The Gruesome
Stock price: 2.310940499040307
P/E ratio: 45.288481201199815
Shares outstanding: 7543563
Book value: 16027005.636167407
P/B ratio: 1.0877094349066905
Market cap (USD): 17432725.243761994
Debt to equity: 2.102420366152584
Current ratio: 0.9545108469015001
Quick ratio: 0.6257200790552929
Effective tax rate (%): 42.96046201688139
Interest coverage ratio: 1.6071534241248424
COGS to revenue (%): 56.0640585691189
SG&A to revenue (%): 7.7672068559131695
Free cash flow (dilution-adjusted): -8951828.756445616
Buyback yield (%): 0
Retained earnings: 11274973.018347524
Inventory turnover: 3.7058589767635337
Receivables turnover: 57.91284329038136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.992745598863201
FCF margin (%): -20.971525935123914
Revenue growth (%): -2.1233377068746817
Rule of 40 score: -23.094863641998597
Financial ratios for RELCHEMQ.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 16066208.79120879
Buffett classification: The Gruesome
Stock price: 2.65922121356904
Shares outstanding: 7543563
Book value: 16133050.645007163
P/B ratio: 1.2434103875885776
Market cap (USD): 20060002.755494505
Debt to equity: 1.9746708828801351
Current ratio: 0.9276952158040647
Quick ratio: 0.559962961542601
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RELCHEMQ.NS — quarterly report dated 2024-12-31
Total revenue: 10750646.92854645
Gross profit: 4164494.6963515556
Operating income: 636554.3769670124
Net income: 22508.450868399577
Capital expenditures: 0
Depreciation & amortization: 408345.96106772346
Owner earnings: 430854.41193612304
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4666044993589
P/E ratio: 206.66667095157953
Shares outstanding: 7543563
Market cap (USD): 18606986.43699732
Effective tax rate (%): -64.48040885860307
Interest coverage ratio: 0.9246528953606502
COGS to revenue (%): 61.26284563123849
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RELCHEMQ.NS — annual report dated 2025-03-31
Total revenue: 41921650.68973579
Gross profit: 21552817.395370584
Operating income: 2057271.4519523028
Net income: 472901.56651858776
Capital expenditures: 1046714.987140519
Operating cash flow: 1263689.5019873742
Depreciation & amortization: 1714671.4987140517
Net tangible assets: 15990343.698854337
Owner earnings: 1140858.0780921201
Return on net tangible assets (%): 7.13466889503982
Capex to operating income (%): 50.87879803840231
Buffett classification: The Good
Stock price: 1.838720970941767
P/E ratio: 29.330643976995997
Shares outstanding: 7543563
Book value: 16048994.622398883
P/B ratio: 0.8642602113132947
Market cap (USD): 13870507.483720388
Debt to equity: 1.914169333297397
Current ratio: 0.9117387703386061
Quick ratio: 0.4999955343932103
Effective tax rate (%): -10.618283245371762
Interest coverage ratio: 0.7298913742259532
COGS to revenue (%): 48.587860829040224
SG&A to revenue (%): 6.8934332558649265
Free cash flow (dilution-adjusted): 210369.4178162263
Buyback yield (%): 0
Retained earnings: 11416401.683422958
Inventory turnover: 2.5195799422724305
Receivables turnover: 20.432457379888778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.743278746092635
FCF margin (%): 0.5018156831971641
Revenue growth (%): -1.78978970637993
Rule of 40 score: -1.2879740231827659
Financial ratios for RELCHEMQ.NS — quarterly report dated 2025-03-31
Total revenue: 9609843.34814122
Gross profit: 5811982.698152911
Operating income: 834182.8384381576
Net income: 215127.42576572363
Capital expenditures: 0
Depreciation & amortization: 493722.2352115969
Net tangible assets: 15990343.698854337
Owner earnings: 708849.6609773205
Return on net tangible assets (%): 4.43298577145723
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.838720970941767
P/E ratio: 16.118943731081433
Shares outstanding: 7543563
Book value: 16048994.622398883
P/B ratio: 0.8642602113132947
Market cap (USD): 13870507.483720388
Debt to equity: 1.914169333297397
Current ratio: 0.9117387703386061
Quick ratio: 0.4999955343932103
Effective tax rate (%): 39.24727632882139
Interest coverage ratio: 1.2240920865283997
COGS to revenue (%): 39.52052611474576
Buyback yield (%): 0
Retained earnings: 11416401.683422958
Inventory turnover: 0.4697870211301416
Receivables turnover: 4.683802078585104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.328785810842124
Revenue growth (%): -10.611487736389396
Rule of 40 score: -10.611487736389396
Financial ratios for RELCHEMQ.NS — quarterly report dated 2025-06-30
Total revenue: 10807828.2237304
Gross profit: 4448303.299789376
Operating income: 826386.6136204073
Net income: 124420.78165223497
Capital expenditures: 0
Depreciation & amortization: 432155.39433653175
Owner earnings: 556576.1759887667
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1174818628598175
P/E ratio: 44.118392710808074
Shares outstanding: 7543563
Market cap (USD): 15973357.833840394
Effective tax rate (%): -11.328656685163857
Interest coverage ratio: 1.0868922849623714
COGS to revenue (%): 58.841839380622474
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 12.466226890377985
Rule of 40 score: 12.466226890377985
Financial ratios for RELCHEMQ.NS — quarterly report dated 2025-09-30
Total revenue: 11220338.218714768
Gross profit: 4432085.682074408
Operating income: 742006.7643742954
Net income: 186335.96392333708
Capital expenditures: 0
Depreciation & amortization: 416877.11386696727
Net tangible assets: 15711104.847801577
Owner earnings: 603213.0777903043
Return on net tangible assets (%): 3.8394058446800496
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7779030439684327
P/E ratio: 24.45642606573807
Shares outstanding: 7543563
Book value: 15760259.301014654
P/B ratio: 0.8509836903003358
Market cap (USD): 13411723.620067641
Debt to equity: 1.8027705150811735
Current ratio: 0.9379237168339706
Quick ratio: 0.5203349461738983
Effective tax rate (%): -55.14878437998685
Interest coverage ratio: 1.1201198134722081
COGS to revenue (%): 60.499535792227846
Buyback yield (%): 0
Inventory turnover: 0.8319373709851691
Receivables turnover: 4.481143289388372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1553025564581465
Revenue growth (%): 3.816770459754652
Rule of 40 score: 3.816770459754652
Financial ratios for RELCHEMQ.NS — quarterly report dated 2025-12-31
Total revenue: 9127893.505625488
Gross profit: 4089940.9602317032
Operating income: 779725.9663584717
Net income: 89060.93349671383
Capital expenditures: 0
Depreciation & amortization: 412041.88481675397
Owner earnings: 501102.8183134678
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4870223905536373
P/E ratio: 18.2413795919343
Shares outstanding: 7543563
Market cap (USD): 11217447.085551968
Effective tax rate (%): 26.08173076923077
Interest coverage ratio: 1.107479075360347
COGS to revenue (%): 55.19293736598605
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -18.648677716320737
Rule of 40 score: -18.648677716320737
Financial ratios for SCANA.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.16533637400228052
Shares outstanding: 461884437
Market cap (USD): 76366298.02166477
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCANA.OL — annual report dated 2022-12-31
Total revenue: 91649797.5708502
Gross profit: 47297570.85020243
Operating income: -2550607.2874493925
Net income: -4504048.582995951
Capital expenditures: 1427125.5060728744
Operating cash flow: 7085020.242914979
Depreciation & amortization: 9068825.910931174
Net tangible assets: 14878542.510121455
Owner earnings: 3137651.8218623484
Buffett classification: The Gruesome
Stock price: 0.10323886639676112
Shares outstanding: 461884437
Book value: 49868421.05263159
P/B ratio: 0.956204842175766
Market cap (USD): 47684425.68218623
Debt to equity: 1.1445098437182868
Current ratio: 0.9336697909156453
Quick ratio: 0.7750540735400144
Interest coverage ratio: -0.60431654676259
COGS to revenue (%): 48.39315295416897
SG&A to revenue (%): 5.157371617890668
Free cash flow (dilution-adjusted): 4732085.020242915
Buyback yield (%): 0
Inventory turnover: 6.639393939393939
Receivables turnover: 5.631218905472637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6187259690325257
FCF margin (%): 5.16322473771397
Rule of 40 score: 5.16322473771397
Financial ratios for SCANA.OL — annual report dated 2023-12-31
Total revenue: 157750491.15913555
Gross profit: 71178781.92534381
Operating income: 8379174.852652259
Net income: 7033398.821218075
Capital expenditures: 3143418.467583497
Operating cash flow: 15510805.500982318
Depreciation & amortization: 9410609.037328094
Net tangible assets: 21994106.09037328
Owner earnings: 13300589.390962671
Return on net tangible assets (%): 60.47342563644483
Capex to operating income (%): 37.51465416178195
Buffett classification: The Good
Stock price: 0.19941060903732807
P/E ratio: 13.095326914944133
Shares outstanding: 461884437
Book value: 57092337.91748525
P/B ratio: 1.6132577548348246
Market cap (USD): 92104656.88703339
Debt to equity: 0.9003785271851344
Current ratio: 1.0373907742328796
Quick ratio: 0.9170900223531802
Effective tax rate (%): -26.548672566371685
Interest coverage ratio: 2.106172839506173
COGS to revenue (%): 54.87888411482659
SG&A to revenue (%): 3.798493056852855
Free cash flow (dilution-adjusted): 12298624.754420433
Buyback yield (%): 0
Inventory turnover: 14.886824324324325
Receivables turnover: 6.359999999999999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.503638719968098
FCF margin (%): 7.796251323245533
Revenue growth (%): 72.12312011620755
Rule of 40 score: 79.91937143945307
Financial ratios for SCANA.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3110687022900763
Shares outstanding: 461884437
Market cap (USD): 143677792.4255725
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCANA.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.25308641975308643
Shares outstanding: 461884437
Market cap (USD): 116896678.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0